The authors are at the Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, USA. saltiel@umich.edu
The phosphatase SHIP2 has been the focus of drug development efforts for diabetes. This distinction is based in part on work suggesting that the molecule is central to the regulation of glucose levels in tissues and blood. An analysis of a SHIP2 knockout mouse changes this viewpoint and provides new directions for therapeutic intervention (pages 199−205).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
